Pegaptanib Sodium
Therapeutic Group
Ocular Vascular Disorder AgentsIndication Dosage
Treatment Of Neovascular (wet) Age-related Macular Degeneration:
By Intravitreal Inj:
- Adult: 300 Mcg Every 6 Weeks, To Be Administered Into The Affected Eye, Review Treatment If No Benefit After 2 Consecutive Injections
Content
- Inj: Pegaptanib (as Sodium Salt) 300 Mcg Vial; Solu-tion For Intravitreal Injection.
Pregnancy
Consult with Doctor Or Caution Advised
Stability
- Vascular Endothelial Growth Factor Inhibitor
Contra Indications
- Severe Intra-ocular Inflammation, Ocular Or Periocular Infection
Precautions
- Severe Intra-ocular Inflammation, Ocular Or Periocular Infection
Lactation
- Consult with Doctor Or Caution Advised
Side Effects
- Headache
- Anterior Chamber Inflammation
- Raised Intra-ocular
- Pressure
- Retinal Haemorrhage Cataract
- Conjunctival Haemorrhage
- Conjunctivitis
- Corneal Dystrophy
- Dry Eye
- Eye Discharge
- Eye Irritation
- Eye Pain
- Flashing Lights
- Local Oedema
- Macular Degeneration
- Mydriasis
- Periorbitalhaematoma
- Photophobia
- Punctate Keratitis
- Rhinorrhea
- Vitreous Disorders
- Vitreous Floaters
- Aortic Aneurysm
- Asthenopia
- Blepharitis
- Chalazion
- Corneal Deposits
- Eye Movement Disorder
- Eyelid Ptosis
- Iritis
- Nasopharyngitis
- Occlusion Of Retinal Blood Vessels
- Optic Nerve Cupping
- Pupillary Disorder
- Rash
- Retinal Detachment
- Retinal Exudates
- Vertigo
- Vitreous Haemorrhage